Bg pattern

IVERTILENE 3 mg TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use IVERTILENE 3 mg TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Ivertilene 3 mg EFG Tablets

ivermectin

Read this package leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the Package Leaflet

  1. What is Ivertilene and what is it used for
  2. What you need to know before you take Ivertilene
  3. How to take Ivertilene
  4. Possible side effects
  5. Storage of Ivertilene
  6. Contents of the pack and other information

1. What is Ivertilene and what is it used for

Ivertilene contains the active substance ivermectin. It is a type of medicine used to treat infections caused by some parasites.

It is used to treat:

  • A gastrointestinal infectioncalled strongyloidiasis (anguilulosis), caused by a type of nematode called Strongyloides stercoralis.
  • A blood infectioncalled microfilaremia due to lymphatic filariasis. It is a condition caused by a larva called Wuchereria bancrofti. Ivermectin does not act against adult worms, only against larvae.
  • Scabies (skin mites). It occurs when tiny mites are introduced under the skin. This can cause intense itching. This medicine should only be taken when your doctor checks or believes you have scabies.

Ivermectin does not prevent you from getting these infections. It does not act against adult worms. Ivermectin should only be taken when your doctor checks or believes you have a parasitic infection.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Ivertilene

Do not take Ivertilene:

  • If you are allergicto ivermectin or any of the other ingredients of this medicine (listed in section 6). The signs of an allergic reaction to a medicine can include a skin rash, difficulty breathing, or fever.
  • If you have ever suffered from a severe skin rash, skin peeling, blisters, or ulcers in the mouth after taking ivermectin.

Warnings and precautions

Consult your doctor before starting to take ivermectina:

  • Severe skin reactions, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported with ivermectin treatment. Stop taking ivermectin and seek medical attention immediately if you notice any of the symptoms described in section 4 related to these severe skin reactions.
  • If you have a weakened immune system.
  • If you live or have lived in an area of Africawhere there are cases of human parasitic infestation with the filarial parasite "Loa loa", also known as "eye worm".

The simultaneous use of diethylcarbamazine citrate (DEC) with ivermectin for the treatment of a concomitant infection with "Onchocerca volvulus" (causing "river blindness") may increase the risk of experiencing side effects that can sometimes be serious.

Children

The safety of using ivermectin in children weighing less than 15 kg has not been evaluated.

Other medicines and Ivertilene

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

If you are pregnant, do not take this medicine unless your doctor tells you to.

Ivermectin is excreted in breast milk. Your doctor may decide to start your treatment one week after the birth of your child.

Driving and using machines

After taking ivermectin, you may experience side effects such as dizziness, drowsiness, tremors, or a feeling of spinning. If you experience these symptoms, do not drive or use machines.

3. How to take Ivertilene

Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

Method of administration

  • The tablets are administered orally.
  • In children under 6 years of age, the tablets should be broken before swallowing.
  • The tablets should be taken with water and on an empty stomach.
  • Do not consume any food during the 2 hours before or after taking the medicine, as the influence of food on the absorption of the medicine in the body is unknown.

How many tablets to take

  • The treatment is a single dose.
  • Your doctor will indicate how many tablets you should take.
  • The number of prescribed tablets should be taken at the same time.
  • The dose will depend on your disease, weight, and height.

For a gastrointestinal infection called strongyloidiasis (anguilulosis)

  • The recommended dose based on body weight is:

Body weight (kg)

Dose (number of tablets)

From 15 to 24

One

From 25 to 35

Two

From 36 to 50

Three

From 51 to 65

Four

From 66 to 79

Five

≥ 80

Six

For a blood infection called "microfilaremia" caused by lymphatic filariasis

  • The recommended dose based on body weight is:

Body weight (kg)

Dose administered every 6 months (number of tablets)

Dose administered every 12 months (number of tablets)

From 15 to 25

One

Two

From 26 to 44

Two

Four

From 45 to 64

Three

Six

From 65 to 84

Four

Eight

  • Administered every 6 months or every 12 months.
  • Alternatively, if it is not possible to determine the weight, the dose of ivermectin can be determined based on the patient's height as follows:

Height (cm)

Dose administered every 6 months (number of tablets)

Dose administered every 12 months (number of tablets)

From 90 to 119

One

Two

From 120 to 140

Two

Four

From 141 to 158

Three

Six

> 158

Four

Eight

For scabies (skin mites)

  • Your doctor will prescribe a dose of 200 micrograms per kilogram of body weight.
  • You will not notice improvement until 4 weeks after treatment.
  • Your doctor may decide to administer a second dose 8-15 days later.

If you take more Ivertilene than you should

If you take more ivermectin than you should, consult your doctor immediately.

There have been reports of decreased alertness and coma in patients who took more ivermectin than they should.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Ivertilene

Take the medication as soon as you remember. Do not take a double dose to make up for forgotten doses.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

These side effects are usually not serious or long-lasting. They may be more likely in people infected with several parasites, especially in the case of the "Loa loa" worm.

The following side effects may occur with this medicine:

Allergic reactions

If you experience an allergic reaction, go to the doctor immediately. The symptoms can include:

  • Sudden fever.
  • Sudden skin reactions (such as rash or itching) or other severe skin reactions.
  • Difficulty breathing.

Stop taking ivermectin and seek medical attention immediately if you notice any of the following symptoms:

Red patches, or circular or coin-shaped patches on the chest, often with central blisters, skin peeling, ulcers in the mouth, throat, nose, genitals, or eyes. These severe skin reactions can be preceded by fever and flu-like symptoms (Stevens-Johnson syndrome, toxic epidermal necrolysis).

Other side effects:

  • Liver disease (acute hepatitis).
  • Changes in the results of some laboratory tests (increased liver enzymes, increased bilirubin in the blood, increased eosinophils).
  • Blood in the urine.
  • Decreased alertness, including coma.

The following side effects will depend on the reason why you are taking this medicine, as well as whether you have any other infection.

People with a gastrointestinal infection called "strongyloidiasis" (anguilulosis)may experience the following side effects:

  • Exceptional weakness.
  • Lack of appetite, stomach pain, constipation, or diarrhea.
  • Nausea or vomiting.
  • Drowsiness or dizziness.
  • Tremors.
  • It is possible to detect adult worms in the stool.

People with a blood infection called "microfilaremia" caused by lymphatic filariasismay experience the following side effects:

  • Sweating or fever.
  • Headache.
  • Exceptional weakness.
  • Muscle, joint, or generalized body pain.
  • Lack of appetite, nausea.
  • Stomach pain (abdominal or epigastric pain).
  • Cough or sore throat.
  • Breathing difficulties.
  • Low blood pressure when standing up or standing (you may feel dizzy or faint).
  • Chills.
  • Dizziness.
  • Pain or discomfort in the testicle.

People with scabies (skin mites)may experience the following side effects:

  • Possible worsening of itching (pruritus) when starting treatment, which usually does not last long.

People with a severe infection with the "Loa loa" wormmay experience the following side effects:

  • Abnormal brain activity.
  • Neck or back pain.
  • Bleeding in the eyes (red eyes).
  • Breathing difficulties.
  • Loss of bladder or bowel control.
  • Difficulty standing or walking.
  • Changes in mental status.
  • Drowsiness or confusion.
  • Lack of response to others or entry into a coma.

People infected with the "Onchocerca volvulus" worm (causing "river blindness")may experience the following side effects:

  • Itching or rash.
  • Muscle or joint pain.
  • Fever.
  • Nausea or vomiting.
  • Swollen lymph nodes.
  • Swelling, especially in the hands, ankles, or feet.
  • Diarrhea.
  • Dizziness.
  • Low blood pressure (hypotension). You may feel dizzy or faint when standing up.
  • Increased heart rate.
  • Headache or fatigue.
  • Changes in vision and other eye problems such as infection, redness, or unusual sensations.
  • Bleeding in the eyes or swelling of the eyelids.
  • Worsening of asthma.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Ivertilene

Keep this medicine out of the sight and reach of children.

Aluminum/Aluminum Blister:

This medicine does not require any special storage temperature. Store in the original packaging to protect from light.

PVC/PVDC Blister:

Do not store above 25 °C. Store in the original packaging to protect from light.

Do not use this medicine after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Contents of the pack and other information

Composition of Ivertilene

  • The active substance is ivermectin. Each tablet contains 3 mg of ivermectin.
  • The other ingredients are microcrystalline cellulose (E460), magnesium stearate (E470b), butylhydroxyanisole (E320), anhydrous citric acid (E330), colloidal anhydrous silica (E551), and pregelatinized corn starch (E1422).

Appearance of the product and packaging contents

Ivertilene 3 mg EFG tablets are white or almost white, round tablets, approximately 5.60 mm in diameter, marked with "Y" on one face and "16" on the other face.

The tablets are available in cardboard boxes with blisters of 1, 4, 2x4, 6, 8, 10, 12, 16, or 20 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder:

Glenmark Arzneimittel GmbH

Industriestr. 31

82194 Gröbenzell

Germany

Manufacturer:

Glenmark Pharmaceuticals s.r.o.

Fibichova 1435

566 17 Vysoké Mýto

Czech Republic

You can obtain further information on this medicine by contacting the local representative of the marketing authorization holder:

Glenmark Farmacéutica, S.L.U.

C/ Retama 7, 7th floor

28045 Madrid

Spain

This medicine is authorized in the EEA member states under the following names:

Netherlands:

Ivermectine Glenmark 3 mg tablets

Germany:

Ivermectin Glenmark 3 mg tablets

Spain:

Ivertilene 3 mg EFG tablets

Finland:

Ivermectin Glenmark

Norway:

Ivermectin Glenmark

Date of last revision of this leaflet:September 2024.

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/).

Online doctors for IVERTILENE 3 mg TABLETS

Discuss questions about IVERTILENE 3 mg TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for IVERTILENE 3 mg TABLETS?
IVERTILENE 3 mg TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in IVERTILENE 3 mg TABLETS?
The active ingredient in IVERTILENE 3 mg TABLETS is ivermectin. This information helps identify medicines with the same composition but different brand names.
Who manufactures IVERTILENE 3 mg TABLETS?
IVERTILENE 3 mg TABLETS is manufactured by Glenmark Arzneimittel Gmbh. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of IVERTILENE 3 mg TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether IVERTILENE 3 mg TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to IVERTILENE 3 mg TABLETS?
Other medicines with the same active substance (ivermectin) include IVERCARE 3 mg TABLETS, IVERGALEN 3 mg TABLETS, IVERMECTIN TEVA 3 mg TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media